Sign In
Buy FLGT
$18.14
-0.560 (-2.99%)
At Close: Jun 03, 2026
Biotech Bonanza - Second Half Outlook
08:24am, Tuesday, 28'th Jul 2020
Biotech is one of the rare industries whose prospects have improved as the year has progressed. A low interest rate environment, a less hostile regulatory environment, and strong investor interest cre
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 27)
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT)
Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO)...
Old West Investment Management Q2 2020 Investor Letter
11:40am, Friday, 24'th Jul 2020
Old West manages long only and long/short investment strategies based upon the companies that we uncover through our simple yet sound investment process.
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
12:00am, Friday, 24'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 23)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Acceleron Pharma Inc (NASDAQ: XLRN)
Aerpio...
Fulgent Genetics (NASDAQ:FLGT) Raised to Strong-Buy at BidaskClub
05:14am, Thursday, 16'th Jul 2020
Fulgent Genetics (NASDAQ:FLGT) was upgraded by analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a note issued to investors on Thursday, BidAskClub reports. Other analysts
Fulgent Genetics to Announce Second Quarter 2020 Financial Results on Tuesday August 4, 2020
12:00pm, Tuesday, 14'th Jul 2020
TEMPLE CITY, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its second quarter 2020
Focusing On Fulgent Genetics
09:09am, Tuesday, 14'th Jul 2020
Today, we take a look at Fulgent Generics, a fast growing and intriguing testing concern. The shares have bounced back nicely since their March lows, and the company is rapidly closing in on breakeven
Hedge Funds Aren’t Crazy About Fulgent Genetics, Inc. (FLGT) Anymore
04:28pm, Thursday, 25'th Jun 2020
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Ma
P/E Ratio Insights for Fulgent Genetics
02:32pm, Wednesday, 17'th Jun 2020
In the current session, Fulgent Genetics Inc. (NASDAQ: FLGT) is trading at $17.66, after a 7.00% spike. Over the past month, the stock increased by 12.52%, and in the past year, by 222.10%. With perfo
Dow Jones Today, Stocks Advance As Active Covid-19 Cases Hit Record; Apple Opens NY Stores; Chegg Leads IBD 50
01:49pm, Wednesday, 17'th Jun 2020
Chegg and biotech Fulgent Genetics outran rising stock futures Wednesday, Apple led the Dow Jones today, even as coronavirus data took a worrying turn.
Fulgent Pops 18% In After-Market On FDA Nod For Covid-19 Home Test
07:05am, Wednesday, 17'th Jun 2020
Fulgent Genetics Inc. (FLGT) said it was granted Emergency Use Authorization (EUA) for its Covid-19 home testing kit by the US Food and Drug
Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19 | MarketScreener
08:06pm, Tuesday, 16'th Jun 2020Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19
08:05pm, Tuesday, 16'th Jun 2020
The company has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for use in the United States. Fulgent Genetics will be offering the testing service through P
Fulgent's COVID-19 Tests Are Ramping Fast, But Their Other Tests Are Suffering (NASDAQ:FLGT)
10:11pm, Wednesday, 10'th Jun 2020
The company's strong growth is likely to suffer as a result of the pandemic, but we think this is only a temporary blip. The company rapidly adjusted and develo
Edited Transcript of FLGT earnings conference call or presentation 4-May-20 8:30pm GMT
06:32am, Friday, 22'nd May 2020
Q1 2020 Fulgent Genetics Inc Earnings Call
